Dvt

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2016-02-05
EMA concludes defective device in ROCKET study does not impact Xarelto's safety
EMA states that a defective device in the ROCKET study does not impact the safety of Xarelto (rivaroxaban).